Radhika Tripuraneni net worth and public holdings

Net worth context built from supported SEC-disclosed public-company holdings, with filing provenance and valuation limits.

Net worth context from calculable public holdings

For net-worth context, Grizzly Bulls can currently identify and value $747.4K in Radhika Tripuraneni's supported SEC-disclosed public-company holdings.

This figure is not a complete personal net-worth estimate. Exact total net worth is not publicly known. This estimate reflects only supported direct public-company holdings that Grizzly Bulls can currently identify and value from SEC filings. It may omit private assets, liabilities, indirect holdings, and unsupported securities.

Supported public holdings
$747.4K
Positions included
1
Source filings
1
Position knowledge through
Oct 10, 2026

Latest SEC-reported relationship

Chief Medical Officer at Viridian Therapeutics, Inc.\DE

Reported in an ownership filing filed Aug 18, 2026. This is filing relationship evidence, not a claim that the role or ownership relationship remains current today.

SEC evidence snapshot

The current profile contains 1 supported position across 1 public company, backed by 1 distinct SEC filing.

The largest included position is Viridian Therapeutics, Inc.\DE at $747.4K, or about 100.0% of the supported public-holdings total.

The latest filing represented was filed Aug 18, 2026. Current values use 1 supported valuation date across the included positions.

Current disclosed public-company holdings

These are supported direct positions traced to SEC ownership filings. Share counts use the current supported share basis, while each value uses the valuation date shown below.

CompanySecurityCurrent basis unitsCurrent valuePosition reportedValuation dateSEC source
Nasdaq:VRDN
Common Stock, $0.01 par value per share40,000$747,400.00Aug 14, 2026Oct 9, 2026Form 4
Filed Aug 18, 2026
0001193125-26-355735

Latest filing represented: Aug 18, 2026. The table includes 1 distinct SEC filing.